MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Activin E is a new guardian protecting against hepatic steatosis via inhibiting lipolysis in white adipose tissue
Activin E is a new guardian protecting against hepatic steatosis via inhibiting lipolysis in white adipose tissue
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Activin E is a new guardian protecting against hepatic steatosis via inhibiting lipolysis in white adipose tissue
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Activin E is a new guardian protecting against hepatic steatosis via inhibiting lipolysis in white adipose tissue
Activin E is a new guardian protecting against hepatic steatosis via inhibiting lipolysis in white adipose tissue

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Activin E is a new guardian protecting against hepatic steatosis via inhibiting lipolysis in white adipose tissue
Activin E is a new guardian protecting against hepatic steatosis via inhibiting lipolysis in white adipose tissue
Journal Article

Activin E is a new guardian protecting against hepatic steatosis via inhibiting lipolysis in white adipose tissue

2025
Request Book From Autostore and Choose the Collection Method
Overview
Hepatic endoplasmic reticulum (ER) stress is implicated in the development of steatosis and its progression to nonalcoholic steatohepatitis (NASH). The ER in the liver can sustain metabolic function by activating defense mechanisms that delay or prevent the progression of nonalcoholic fatty liver disease (NAFLD). However, the precise mechanisms by which the ER stress response protects against NAFLD remain largely unknown. Recently, activin E has been linked to metabolic diseases such as insulin resistance and NAFLD. However, the physiological conditions and regulatory mechanisms driving hepatic Inhbe expression (which encodes activin E) as well as the metabolic role of activin E in NAFLD require further investigation. Here we found that hepatic Inhbe expression increased under prolonged fasting and ER stress conditions, which was mediated by ATF4, as determined by promoter analysis in a mouse model. Consistently, a positive correlation between INHBE and ATF4 expression levels in relation to NAFLD status was confirmed using public human NAFLD datasets. To investigate the role of activin E in hepatic steatosis, we assessed the fluxes of the lipid metabolism in an Inhbe -knockout mouse model. These mice displayed a lean phenotype but developed severe hepatic steatosis under a high-fat diet. The deficiency of Inhbe resulted in increased lipolysis in adipose tissue, leading to increased fatty acid influx into the liver. Conversely, hepatic overexpression of Inhbe ameliorated hepatic steatosis by suppressing lipolysis in adipose tissue through ALK7–Smad signaling. In conclusion, activin E serves as a regulatory hepatokine that prevents fatty acid influx into the liver, thereby protecting against NAFLD. Activin E protects against fatty liver by inhibiting fat breakdown Hepatic endoplasmic reticulum (ER) stress is associated with nonalcoholic fatty liver disease (NAFLD). Although it is known that the liver’s ER can activate defense mechanisms to slow NAFLD progression, the specific protective processes remain unclear. Recent studies have identified activin E, encoded by the Inhbe gene, as being linked to metabolic conditions such as insulin resistance and NAFLD. This research demonstrates that hepatic Inhbe expression increases during ER stress, a process regulated by ATF4. Loss of Inhbe led to severe hepatic steatosis due to enhanced lipolysis in adipose tissue. By contrast, hepatic overexpression of Inhbe alleviated hepatic steatosis by suppressing adipose tissue lipolysis through ALK7–Smad signaling. These findings suggest that activin E functions as a regulatory hepatokine, protecting against NAFLD by preventing excessive fatty acid influx into the liver through the inhibition of adipose lipolysis. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.